ESMO 2018

CARE™ Perspectives: ESMO 2018 Report



13 Mar 2018

This CARE™ Perspectives Conference Report has been developed with Dr. Sebastien Hotte, CARE™ Genitourinary (GU) Faculty. This GU-focused report provides a summary of compelling stories and news presented at ESMO 2018 (Munich, Germany), framed in a Canadian perspective.

Dr. Sebastien Hotte is pleased to provide background and perspectives on major clinical trials in prostate cancer (SPARTAN, LATITUDE, STAMPEDE and PROSPER); renal cell carcinoma (RCC) – emphasis on use of predictive biomarkers and emerging targeted therapies; and urothelial carcinoma (UC).